DocMorris AG (ZRSEF)
ZRSEF Stock Price Chart
Explore DocMorris AG interactive price chart. Choose custom timeframes to analyze ZRSEF price movements and trends.
ZRSEF Company Profile
Discover essential business fundamentals and corporate details for DocMorris AG (ZRSEF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
28 Sept 2018
Employees
1.45K
CEO
Walter Hess
Description
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers consumer health, beauty, and personal care products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. The company was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
ZRSEF Financial Timeline
Browse a chronological timeline of DocMorris AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Aug 2026
Upcoming earnings on 11 Mar 2026
Earnings released on 19 Aug 2025
Revenue for the quarter reached $328.96M , beating expectations by +9.15%.
Earnings released on 8 May 2025
EPS came in at -$5.54 , while revenue for the quarter reached $573.40M , beating expectations by +98.89%.
Earnings released on 20 Aug 2024
EPS came in at -$3.59 falling short of the estimated -$2.84 by -26.67%, while revenue for the quarter reached $553.88M , beating expectations by +129.64%.
Earnings released on 21 Mar 2024
EPS came in at -$5.89 falling short of the estimated -$2.57 by -129.57%, while revenue for the quarter reached $591.94M , missing expectations by -2.76%.
Earnings released on 30 Jun 2023
EPS came in at -$5.18 falling short of the estimated -$0.58 by -797.82%, while revenue for the quarter reached $516.14M , missing expectations by -28.01%.
Earnings released on 23 Mar 2023
EPS came in at -$8.21 falling short of the estimated -$3.39 by -142.21%, while revenue for the quarter reached $847.97M , missing expectations by -8.83%.
Earnings released on 20 Oct 2022
EPS came in at -$8.65 falling short of the estimated -$5.18 by -67.21%, while revenue for the quarter reached $860.13M , missing expectations by -15.30%.
Earnings released on 24 Mar 2022
EPS came in at -$16.81 falling short of the estimated -$4.17 by -302.96%, while revenue for the quarter reached $969.68M , missing expectations by -7.66%.
Earnings released on 21 Oct 2021
EPS came in at -$8.69 falling short of the estimated -$4.01 by -116.70%, while revenue for the quarter reached $909.09M , beating expectations by +0.82%.
Earnings released on 14 Jun 2021
EPS came in at -$9.84 , while revenue for the quarter reached $880.99M , missing expectations by -9.34%.
Earnings released on 21 Oct 2020
EPS came in at -$6.38 , while revenue for the quarter reached $738.22M , missing expectations by -15.53%.
ZRSEF Stock Performance
Access detailed ZRSEF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.